Copper regulates cyclic-AMP-dependent lipolysis. 2016

Lakshmi Krishnamoorthy, and Joseph A Cotruvo, and Jefferson Chan, and Harini Kaluarachchi, and Abigael Muchenditsi, and Venkata S Pendyala, and Shang Jia, and Allegra T Aron, and Cheri M Ackerman, and Mark N Vander Wal, and Timothy Guan, and Lukas P Smaga, and Samouil L Farhi, and Elizabeth J New, and Svetlana Lutsenko, and Christopher J Chang
Department of Chemistry, University of California, Berkeley, California, USA.

Cell signaling relies extensively on dynamic pools of redox-inactive metal ions such as sodium, potassium, calcium and zinc, but their redox-active transition metal counterparts such as copper and iron have been studied primarily as static enzyme cofactors. Here we report that copper is an endogenous regulator of lipolysis, the breakdown of fat, which is an essential process in maintaining body weight and energy stores. Using a mouse model of genetic copper misregulation, in combination with pharmacological alterations in copper status and imaging studies in a 3T3-L1 white adipocyte model, we found that copper regulates lipolysis at the level of the second messenger, cyclic AMP (cAMP), by altering the activity of the cAMP-degrading phosphodiesterase PDE3B. Biochemical studies of the copper-PDE3B interaction establish copper-dependent inhibition of enzyme activity and identify a key conserved cysteine residue in a PDE3-specific loop that is essential for the observed copper-dependent lipolytic phenotype.

UI MeSH Term Description Entries
D008066 Lipolysis The metabolic process of breaking down LIPIDS to release FREE FATTY ACIDS, the major oxidative fuel for the body. Lipolysis may involve dietary lipids in the DIGESTIVE TRACT, circulating lipids in the BLOOD, and stored lipids in the ADIPOSE TISSUE or the LIVER. A number of enzymes are involved in such lipid hydrolysis, such as LIPASE and LIPOPROTEIN LIPASE from various tissues. Lipolyses
D003300 Copper A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. Copper-63,Copper 63
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D054684 Cyclic Nucleotide Phosphodiesterases, Type 3 A cyclic nucleotide phosphodiesterase subfamily that is inhibited by the binding of CYCLIC GMP to an allosteric domain found on the enzyme and through phosphorylation by regulatory kinases such as PROTEIN KINASE A and PROTEIN KINASE B. The two members of this family are referred to as type 3A, and type 3B, and are each product of a distinct gene. In addition multiple enzyme variants of each subtype can be produced due to multiple alternative mRNA splicing. Cyclic Nucleotide Phosphodiesterase PDE3 Family,Cyclic Nucleotide Phosphodiesterases, Type 3A,Cyclic Nucleotide Phosphodiesterases, Type 3B,Phosphodiesterase 3A,Phosphodiesterase 3B,Phosphodiesterase III,cGMP-Inhibited Cyclic Nucleotide Phosphodiesterase,cGMP-Inhibited Phosphodiesterase,Phosphodiesterase, cGMP-Inhibited,cGMP Inhibited Cyclic Nucleotide Phosphodiesterase,cGMP Inhibited Phosphodiesterase
D058987 Phosphodiesterase 3 Inhibitors Compounds that specifically inhibit PHOSPHODIESTERASE 3. PDE3 Inhibitor,Phosphodiesterase 3 Inhibitor,Phosphodiesterase Type 3 Inhibitor,PDE-3 Inhibitors,PDE3 Inhibitors,Phosphodiesterase Type 3 Inhibitors,3 Inhibitor, Phosphodiesterase,Inhibitor, PDE3,Inhibitor, Phosphodiesterase 3,Inhibitors, PDE-3,Inhibitors, PDE3,Inhibitors, Phosphodiesterase 3,PDE 3 Inhibitors

Related Publications

Lakshmi Krishnamoorthy, and Joseph A Cotruvo, and Jefferson Chan, and Harini Kaluarachchi, and Abigael Muchenditsi, and Venkata S Pendyala, and Shang Jia, and Allegra T Aron, and Cheri M Ackerman, and Mark N Vander Wal, and Timothy Guan, and Lukas P Smaga, and Samouil L Farhi, and Elizabeth J New, and Svetlana Lutsenko, and Christopher J Chang
July 1981, The Journal of pharmacology and experimental therapeutics,
Lakshmi Krishnamoorthy, and Joseph A Cotruvo, and Jefferson Chan, and Harini Kaluarachchi, and Abigael Muchenditsi, and Venkata S Pendyala, and Shang Jia, and Allegra T Aron, and Cheri M Ackerman, and Mark N Vander Wal, and Timothy Guan, and Lukas P Smaga, and Samouil L Farhi, and Elizabeth J New, and Svetlana Lutsenko, and Christopher J Chang
October 2003, The Journal of biological chemistry,
Lakshmi Krishnamoorthy, and Joseph A Cotruvo, and Jefferson Chan, and Harini Kaluarachchi, and Abigael Muchenditsi, and Venkata S Pendyala, and Shang Jia, and Allegra T Aron, and Cheri M Ackerman, and Mark N Vander Wal, and Timothy Guan, and Lukas P Smaga, and Samouil L Farhi, and Elizabeth J New, and Svetlana Lutsenko, and Christopher J Chang
July 1976, Biochemical pharmacology,
Lakshmi Krishnamoorthy, and Joseph A Cotruvo, and Jefferson Chan, and Harini Kaluarachchi, and Abigael Muchenditsi, and Venkata S Pendyala, and Shang Jia, and Allegra T Aron, and Cheri M Ackerman, and Mark N Vander Wal, and Timothy Guan, and Lukas P Smaga, and Samouil L Farhi, and Elizabeth J New, and Svetlana Lutsenko, and Christopher J Chang
February 1976, Acta physiologica Scandinavica,
Lakshmi Krishnamoorthy, and Joseph A Cotruvo, and Jefferson Chan, and Harini Kaluarachchi, and Abigael Muchenditsi, and Venkata S Pendyala, and Shang Jia, and Allegra T Aron, and Cheri M Ackerman, and Mark N Vander Wal, and Timothy Guan, and Lukas P Smaga, and Samouil L Farhi, and Elizabeth J New, and Svetlana Lutsenko, and Christopher J Chang
January 1985, Advances in cyclic nucleotide and protein phosphorylation research,
Lakshmi Krishnamoorthy, and Joseph A Cotruvo, and Jefferson Chan, and Harini Kaluarachchi, and Abigael Muchenditsi, and Venkata S Pendyala, and Shang Jia, and Allegra T Aron, and Cheri M Ackerman, and Mark N Vander Wal, and Timothy Guan, and Lukas P Smaga, and Samouil L Farhi, and Elizabeth J New, and Svetlana Lutsenko, and Christopher J Chang
September 2018, Proteomes,
Lakshmi Krishnamoorthy, and Joseph A Cotruvo, and Jefferson Chan, and Harini Kaluarachchi, and Abigael Muchenditsi, and Venkata S Pendyala, and Shang Jia, and Allegra T Aron, and Cheri M Ackerman, and Mark N Vander Wal, and Timothy Guan, and Lukas P Smaga, and Samouil L Farhi, and Elizabeth J New, and Svetlana Lutsenko, and Christopher J Chang
July 1999, Molecular and cellular biology,
Lakshmi Krishnamoorthy, and Joseph A Cotruvo, and Jefferson Chan, and Harini Kaluarachchi, and Abigael Muchenditsi, and Venkata S Pendyala, and Shang Jia, and Allegra T Aron, and Cheri M Ackerman, and Mark N Vander Wal, and Timothy Guan, and Lukas P Smaga, and Samouil L Farhi, and Elizabeth J New, and Svetlana Lutsenko, and Christopher J Chang
January 1980, Advances in cyclic nucleotide research,
Lakshmi Krishnamoorthy, and Joseph A Cotruvo, and Jefferson Chan, and Harini Kaluarachchi, and Abigael Muchenditsi, and Venkata S Pendyala, and Shang Jia, and Allegra T Aron, and Cheri M Ackerman, and Mark N Vander Wal, and Timothy Guan, and Lukas P Smaga, and Samouil L Farhi, and Elizabeth J New, and Svetlana Lutsenko, and Christopher J Chang
September 1987, Molecular and cellular biology,
Lakshmi Krishnamoorthy, and Joseph A Cotruvo, and Jefferson Chan, and Harini Kaluarachchi, and Abigael Muchenditsi, and Venkata S Pendyala, and Shang Jia, and Allegra T Aron, and Cheri M Ackerman, and Mark N Vander Wal, and Timothy Guan, and Lukas P Smaga, and Samouil L Farhi, and Elizabeth J New, and Svetlana Lutsenko, and Christopher J Chang
January 2011, PloS one,
Copied contents to your clipboard!